Sign in
Not yet recruitingNo phase

Small Study Comparing Two Pain Medicines in Teenagers for Pain Control After Scoliosis Corrective Surgery.

Key facts

Who runs it
University of Malaya
Where
Malaysia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
114 people, planned
Started
2 Feb 2026
Expected to end
30 Jan 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Ketamine-Morphine PCA
  • Morphine (Intravenous patient-controlled analgesia)
Record updated
5 March 2026

Who can take part

Age
10 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Aged > 10 years old
  • Idiopathic scoliosis scheduled for single-stage posterior spinal fusion (PSF)
  • American Society of Anaesthesiologists (ASA) physical status I-II

Who cannot take part

  • Chronic opioid therapy or pre-operative pain > 3 months
  • Concomitant monoamine-oxidase inhibitor or tricyclic antidepressant therapy
  • Known hypersensitivity to morphine, ketamine or formulation excipients
  • Uncontrolled asthma or severe restrictive lung disease
  • Cardiac disease or clinically significant arrhythmia
  • Epilepsy
  • History of severe postoperative delirium
  • Hepatic dysfunction (ALT or AST > 2 × upper limit of normal)
  • Renal impairment (eGFR ≤ 60 mL min-¹ 1·73 m-²)
  • Intellectual disability precluding PCA use

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate whether adding low-dose ketamine to PCA morphine reduces opioid requirements after posterior spinal fusion surgery in adolescent idiopathic scoliosis patients. Selected patients aged 10-18 years undergoing elective AIS surgery at University Malaya Medical Centre will be randomised to ketamine-morphine or morphine-only PCA. The primary outcome is cumulative morphine consumption at 48 hours, with secondary outcomes including pain scores, opioid-related adverse effects, time to ambulation, and patient satisfaction. This study aligns with national priorities for safe opioid stewardship and enhanced peri-operative care in Malaysia.

The 2 groups in the trial

  • Ketamine-Morphine PCA (1:1 ratio)Treatment being tested

    This group receives a ketamine-morphine PCA solution (1 mg mL-¹ + 1 mg mL-¹). This device deliver a 1 mL bolus, enforce a five-minute lock-out and cap delivery at 20 mL per four hours, with no background infusion. The patient will use PCA for at least 48 hours duration.

    Treatment: Ketamine-Morphine PCA

  • Morphine only PCAExisting treatment, for comparison

    This group receives morphine alone PCA (1 mg mL-¹). This device deliver a 1 mL bolus, enforce a five-minute lock-out and cap delivery at 20 mL per four hours, with no background infusion. The patient will use PCA for at least 48 hours duration.

    Treatment: Morphine (Intravenous patient-controlled analgesia)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Patient-Controlled Analgesia (PCA) With Ketamine-Morphine (PCA KetaMorph) vs PCA Morphine for Postoperative Analgesia in Idiopathic Scoliosis Surgery - A Randomized Controlled Trial
Record updated
5 March 2026